```html

Keratoderma Palmaris et Plantaris

What is Keratoderma Palmaris et Plantaris?

Keratoderma palmaris et plantaris (KPP) is a descriptive term for thickening (hyperkeratosis) of the skin on the palms of the hands and the soles of the feet. The condition may appear as rough, callus‑like plaques, sometimes with a yellow‑white sheen, and can range from mild scaling to painfully fissured skin. While “keratoderma” simply means “thick skin,” the addition of “palmaris et plantaris” pinpoints the location—palms and soles.

KPP can be primary (genetic) or secondary to other medical conditions, medications, infections, or environmental factors. Because the palms and soles are weight‑bearing and essential for daily tasks, even modest keratoderma can interfere with grip, walking, and quality of life.

Common Causes

More than a dozen disorders can lead to palmar‑plantar keratoderma. The most frequent causes are listed below.

• Genetic (hereditary) keratodermas – e.g.,
  • Diffuse palmoplantar keratoderma (Vörner type)
  • Focal palmoplantar keratoderma (Howel‑Evans syndrome)
  • Papular keratoderma (Papillon‑Lefèvre syndrome)
• Eczematous dermatitis – chronic irritant or allergic contact dermatitis can induce secondary hyperkeratosis.
• Psoriasis – palmoplantar pustulosis or plaque psoriasis often involves thickened plaques on palms and soles.
• Fungal infections (tinea pedis/manuum) – chronic infection stimulates hyperkeratotic response.
• Systemic diseases –
  • Hyperlipidemia (especially type IIa)
  • Diabetes mellitus (due to neuropathy and dryness)
  • Hypothyroidism
• Medication‑induced keratoderma – retinoids, chemotherapy agents (e.g., methotrexate), and B‑complex vitamin excess.
• Infectious causes – HIV, leprosy, and syphilis can produce palmar‑plantar hyperkeratosis.
• Occupational or mechanical stress – athletes, manual laborers, and musicians who apply repetitive pressure to hands/feet.
• Nutrition deficiencies – zinc or biotin deficiency may manifest with keratoderma.
• Autoimmune/connective‑tissue diseases – scleroderma and lupus erythematosus (rare).

Associated Symptoms

Patients with KPP often notice other skin or systemic signs that can point to the underlying cause.

• Itching or burning sensation on affected areas
• Painful fissures or cracks, especially after walking or using the hands
• Blistering or pustules (common in psoriasis‑related KPP)
• Dry, scaly skin on other body sites (e.g., elbows, knees)
• Systemic clues such as:
  • Joint pain or swelling (psoriatic arthritis)
  • Recurrent infections (immunodeficiency)
  • Hair loss, nail dystrophy, or oral ulcers (autoimmune disease)
• Elevated cholesterol or triglyceride levels (in lipid‑related keratoderma)
• Family history of similar skin thickening (suggesting a hereditary form)

When to See a Doctor

Most cases of mild keratoderma can be managed with topical measures, but certain warning signs merit prompt medical evaluation.

• Rapid spread or sudden appearance of thickened plaques.
• Severe pain, deep fissures, or bleeding that limits daily activities.
• Fever, chills, or signs of infection (redness, warmth, pus).
• Accompanying unexplained weight loss, night sweats, or fatigue.
• New onset in a child or teenager without an obvious trigger.
• History of heart disease, high cholesterol, or diabetes combined with skin changes – to assess systemic involvement.

Diagnosis

Diagnosing KPP involves a combination of history‑taking, physical examination, and targeted tests.

1. Clinical Evaluation

• Detailed skin examination of the palms, soles, and any other involved sites.
• Assessment of pattern (diffuse vs. focal) and texture (smooth, gritty, verrucous).
• Family pedigree to uncover hereditary patterns.

2. Laboratory Tests

• Complete blood count (CBC) and metabolic panel – to screen for diabetes, thyroid disease, or infection.
• Lipid profile – elevated LDL or triglycerides suggest a metabolic cause.
• Serologic tests for HIV, syphilis, or autoimmune markers if clinical suspicion exists.
• Zinc or biotin levels if nutritional deficiency is suspected.

3. Skin‑Specific Investigations

• Skin scraping or KOH preparation – detects fungal elements.
• Patch testing – identifies contact allergens.
• Skin biopsy – histology can differentiate psoriatic plaques from other keratodermas and may reveal characteristic cholesterol deposits in lipid‑related forms.
• Genetic testing – in suspected hereditary keratoderma, sequencing of genes such as KRT9 or SLURP1 may be performed.

Treatment Options

Therapy is guided by the underlying cause, severity of hyperkeratosis, and patient preferences. A multimodal approach often yields the best results.

1. General Skin Care

• Gentle, fragrance‑free moisturizers (e.g., urea 10 % or lactic acid creams) applied 2–3 times daily.
• Soaking the affected area in warm water for 10–15 minutes, followed by gentle exfoliation with a pumice stone or a soft brush, can soften plaques before moisturizing.
• Avoid harsh soaps, alcohol‑based sanitizers, and prolonged exposure to hot water.

2. Topical Medications

• Keratin‑softening agents – 10–20 % urea, salicylic acid 2 %, or alpha‑hydroxy acids (glycolic/lactic) to reduce thickness.
• Corticosteroids – low‑ to mid‑potency steroids (e.g., triamcinolone 0.1 %) for inflammatory keratoderma or eczematous components; limit to 2 weeks to avoid skin atrophy.
• Calcipotriene (Vitamin D analog) – useful in psoriasis‑related KPP.
• Topical retinoids – tretinoin 0.025 % or adapalene gel can normalize keratinocyte turnover; start with low concentration to minimize irritation.

3. Systemic Therapies

• Oral retinoids – acitretin (25–50 mg daily) is the gold standard for severe hereditary or psoriasis‑related keratoderma; monitor liver function and lipid profile.
• Biologic agents – TNF‑α inhibitors (adalimumab, etanercept) or IL‑17 inhibitors (secukinumab) are indicated for refractory palmoplantar psoriasis.
• Statins or fibrates – in lipid‑associated keratoderma, treating hyperlipidemia often improves skin changes.
• Antifungal therapy – oral terbinafine or itraconazole for chronic tinea infections.

4. Procedural Options

• Mechanical debridement – professional keratolysis using a scalpel or dermabrasion for stubborn plaques.
• Laser therapy – CO₂ or erbium:YAG lasers can precisely remove hyperkeratotic tissue with minimal downtime.
• Phototherapy – PUVA or narrowband UVB may help in extensive palmoplantar psoriasis.

5. Lifestyle & Supportive Measures

• Wear cushioned, breathable footwear with moisture‑wicking socks; change socks frequently.
• Use protective gloves (cotton or soft leather) when handling chemicals or performing repetitive manual work.
• Maintain optimal glycemic control in diabetes and treat thyroid disorders promptly.
• Quit smoking and limit alcohol, as both can worsen skin barrier function.

Prevention Tips

While not all cases are preventable, several strategies can reduce the risk of developing or worsening KPP.

• Keep hands and feet clean and moisturized—apply emollient after each wash.
• Avoid prolonged exposure to irritants (detergents, solvents) and use barrier creams.
• Manage systemic conditions (cholesterol, diabetes, thyroid) with medication and lifestyle changes.
• If you have a known hereditary keratoderma, discuss genetic counseling and early treatment with a dermatologist.
• Inspect feet daily, especially if you have diabetic neuropathy, to catch early cracks or infections.
• Choose well‑fitting shoes that allow ventilation; rotate footwear to let them dry.
• Limit use of over‑the‑counter harsh exfoliants; instead, rely on physician‑recommended keratolytics.

Emergency Warning Signs

Key Take‑aways

Keratoderma palmaris et plantaris is a manifestation of thickened skin on the palms and soles that can arise from genetic, inflammatory, infectious, metabolic, or mechanical origins. Early identification of the underlying cause, coupled with proper skin care, topical and systemic therapies, and lifestyle modifications, can dramatically improve comfort and function. When pain, infection, or systemic symptoms develop, prompt professional evaluation is essential.

For personalized advice, schedule an appointment with a dermatologist or a primary‑care physician who can order the appropriate tests and tailor treatment to your specific situation.

---

References:

1. Mayo Clinic. “Keratoderma.” Accessed March 2024. https://www.mayoclinic.org/diseases-conditions/keratoderma
2. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). “Palmoplantar Keratoderma.” 2023. https://www.niams.nih.gov/health-topics/palmoplantar-keratoderma
3. Cleveland Clinic. “Palmoplantar Psoriasis.” 2024. https://my.clevelandclinic.org/health/diseases/22409-palmoplantar-psoriasis
4. World Health Organization. “Guidelines for the Management of Dermatophytoses.” 2022.
5. American Academy of Dermatology. “Management of Hyperkeratotic Skin Disorders.” 2023. https://www.aad.org/public/diseases/a-z/palmoplantar-keratoderma-treatment

```